Login
E-mail
Password
Mostra password
Ricorda
Password dimenticata?
Iscriviti gratuitamente
Registrazione
Registrazione
Parametri
Parametri
Quotazioni dinamiche 
OFFON

I Leader della Finanza

Ultime notizieSocietÓMercatiEconomia & ForexMaterie PrimeTassiLeader della FinanzaPro. della FinanzaAgendaSettori 
HomeTutte le notizieLe notizie pi¨ letteBiografie dei Leader della finanza
Portrait de David F. Hale
EtÓ : 72
Patrimonio pubblico : 1 098 982 USD
Principali societÓ : Oncternal Therapeutics, Inc. - Biocept, Inc. - Dermata Therapeutics, Inc.
Riassunto 
Mr. David F. Hale is a Chairman at Dermata Therapeutics LLC, a Chairman at Recros Medica, Inc., an Executive Chairman at MDRejuvena, Inc., a Non-Executive Chairman at Biocept, Inc., a Chairman at Advantar Laboratories, Inc., a Chairman & Chief Executive Officer at Hale BioPharma Ventures LLC, a Chairman at Oncternal Therapeutics, Inc., an Advisor at Windamere Venture Partners LLC, a Chairman at Intrepid Therapeutics, Inc., a Chairman at Rady Children's Institute for Genomic Medicine, a Chairman at Rich Diagnostics, Inc., a Chairman at Ridge Diagnostics, Inc., a Chairman at Zerigo Health, Inc., an Executive Chairman at Neurana Pharmaceuticals, Inc. and a General Partner at Hale Trading Co. LP.

He is on the Board of Directors at Adigica Health, Inc., Neurelis, Inc., BIOCOM, Idun Pharmaceuticals, Inc., San Diego Regional Economic Development Corp., Rady Children's Hospital & Health Center of San Diego and The Salk Institute for Biological Studies. Mr. Hale was previously employed as an Independent Non-Executive Director by Cassiopea SpA, a Chairman by Agility Clinical, Inc., a Chairman by Conatus Pharmaceuticals, Inc., a Non-Executive Chairman by Somaxon Pharmaceuticals, Inc., a Chairman by SkinMedica, Inc., a Chairman by Santarus, Inc., a Chairman by Micromet, Inc., a Chairman by CancerVax Corp., a President & Chief Executive Officer by Women First HealthCare, Inc., an Executive Chairman & Chief Executive Officer by Metabasis Therapeutics, Inc., a Chairman, President & Chief Executive Officer by Gensia-Sicor, Inc., a Chairman by Viagene, Inc., a President, Chief Executive & Operating Officer by Hybritech, Inc., a General Manager & Vice President by BBL Microbiology Systems, a VP & General Manager-BBL Microbiology Systems by Becton, Dickinson & Co., a Trustee by CONNECT, a Chairman by CRISI Medical Systems, Inc., a Chairman by Oncternal Oncology, Inc., and a Principal by Ortho Pharmaceutical Corp.

He also served on the board at Verus Pharmaceuticals, Inc.,


Posti e reponsabilitÓ di David F. Hale 
NomeTitolo Da
Oncternal Therapeutics, Inc.
(Biotecnologia)
Chairman 2018
Biocept, Inc.
(Fornitura medica)
Director -
Dermata Therapeutics, Inc.
(Biotecnologia)
Lead Independent Director 2021
Hale BioPharma Ventures LLC Chairman & Chief Executive Officer 2006
Ridge Diagnostics, Inc. Chairman -
Rich Diagnostics, Inc. Chairman -
Intrepid Therapeutics, Inc. Chairman -
Rady Children's Institute for Genomic Medicine Chairman -
Idun Pharmaceuticals, Inc. Director -
MDRejuvena, Inc. Executive Chairman 2013
Rady Children's Hospital & Health Center of San Diego Trustee 1986
BIOCOM Director 1995
San Diego Regional Economic Development Corp. Director -
Neurelis, Inc. Director -
Adigica Health, Inc. Director 2016
Neurana Pharmaceuticals, Inc. Executive Chairman -
The Salk Institute for Biological Studies Trustee -
Hale Trading Co. LP General Partner -


Participazioni di David F. Hale 
NomeAzioni%Valorizzazione
Dermata Therapeutics, Inc. (DRMA)
(Biotecnologia)
623 2547,48%1 084 462 USD
Biocept, Inc. (BIOC)
(Fornitura medica)
4 0110,024%14 520 USD
Oncternal Therapeutics, Inc. (ONCT)
(Biotecnologia)
00,0000%0 USD


David F. Hale: network personale 
Le notizie pi¨ lette 
11/01JAMIE DIMON: Dimon di JPMorgan dice che la crescita dei prestiti al consumo potrebbe richiedere 6-9 mesi per tornare alla normalità
MR
14/01JACK DORSEY: Block di Jack Dorsey per costruire un sistema aperto di estrazione di bitcoin
MR
14/01ELON MUSK: Merce Tesla acquistabile con dogecoin, dice Musk in un tweet
MR
10/01BRUNELLO CUCINELLI: Il gruppo di lusso Cucinelli registra un salto del 31% nelle vendite nel 2021
MR
12/01MARTIN SORRELL: La S4 di Sorrell dice che il trading è ben al di sopra della guidance
MR
10/01Estelle Brachlianoff diventerà il prossimo CEO di Veolia
MR
13/01L'australiana Crown riceve un'offerta di acquisto più alta da Blackstone
MR
11/01ROBERT WALTERS: Il reclutatore Robert Walters aumenta il reddito trimestrale mentre le assunzioni aumentano
MR
14/01ANDREA ORCEL: ESCLUSIVA-Tribunale Madrid riduce indennizzo Orcel a 51,4 million euro - documento
RE
07/01TIM COOK: Apple, Ad Tim Cook ha guadagnato in 2021 oltre 1.400 volte un dipendente medio
RE
Pi¨ notizie


© 2022 People and Ownership :   
David F. Hale : connessioni